This is an external link. Click “OK” to continue.
Learn about the benefits of otenaproxesul’s new formulation, dive into Antibe’s recently released data and Phase II planning, and explore the future of pain management. As the opioid crisis drives prescribers, patients, payors and policymakers toward non-addictive alternatives, nonsteroidal anti-inflammatory drugs (NSAIDs) are increasingly employed to treat acute pain. However, today’s NSAIDs can cause … Continued
Join Dr. Joseph Stauffer, Antibe’s Chief Medical Officer, as he chairs the opening day of the USA Clinical Trials Innovation & Outsourcing Programme. The event aims to help participants learn, collaborate and contribute to the advancement of clinical trials industry.
Please sign up to our mailing list to receive news updates via email.